Morphic Holding Inc (MORF)
$0.00 $0.00 (0.00%) 4:38 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$2.86B -
Day's Range
- - - -
Volume
- -
52 Week Low / High
$25.25 - $57.00 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
MORF's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 3
- Strong Buy
- 0
- Buy
- 7
- Hold
- 0
- Sell
- 0
- Strong Sell
- $61.50
- Target Price
Company News
-
Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease — Aug 16th, 2024
Broadens Lilly's immunology pipeline with Morphic's oral integrin therapies, including MORF-057 Reinforces the company's strategy of delivering potential first or best-in-class therapies in the field of gastroenterology INDIANAPOLIS, Aug. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (N...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$